This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blázquez, J.
Right arrow Articles by Baquero, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blázquez, J.
Right arrow Articles by Baquero, F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 1998, p. 1042-1044, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

A237T as a Modulating Mutation in Naturally Occurring Extended-Spectrum TEM-Type beta -Lactamases

Jesús Blázquez,* María-Cristina Negri, María-Isabel Morosini, J. M. Gómez-Gómez, and Fernando Baquero

Servicio de Microbiología, Hospital Ramón y Cajal, Madrid 28034, Spain

Received 25 August 1997/Returned for modification 17 December 1997/Accepted 3 March 1998

A TEM-1 beta -lactamase derivative containing the single amino acid substitution A237T slightly increased (from 24 to 32 µg/ml) the cephalothin MIC for Escherichia coli RYC1000 but did not influence the activities of cefotaxime, ceftazidime, and aztreonam (MICs of 0.03, 0.12, and 0.06 µg/ml, respectively). Despite its apparent neutrality, addition of the A237T mutation to the pair of mutations characterizing TEM-10 (R164S and E240K) had a strong effect on substrate preference. Ceftazidime and aztreonam MICs decreased from 128 and 16 µg/ml to 16 and 2 µg/ml, respectively. In contrast, the cefotaxime MIC increased from 0.5 to 4 µg/ml. The acquisition of apparently neutral or even deleterious mutations results in a very effective mechanism of resistance to different beta -lactams that may be simultaneously or subsequently present in the environment. We propose here that the mutation in position 237 is an example of a modulating mutation and that consideration of this type of mutation may be important for understanding the evolution of beta -lactamases.


* Corresponding author. Mailing address: Servicio de Microbiología, Hospital Ramón y Cajal, Carretera de Colmenar Km 9.100, Madrid 28034, Spain. Phone: (34)-1-336 83 30. Fax: (34)-1-336 88 09 or -336 90 16. E-mail: jesus.blazquez{at}hrc.es.


Antimicrobial Agents and Chemotherapy, May 1998, p. 1042-1044, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Mroczkowska, J. E., Barlow, M. (2008). Fitness Trade-Offs in blaTEM Evolution. Antimicrob. Agents Chemother. 52: 2340-2345 [Abstract] [Full Text]  
  • Li, H., Li, J. B. (2005). Detection of Five Novel CTX-M-Type Extended Spectrum Beta-Lactamases with One to Three CTX-M-14 Point Mutations in Isolates from Hefei, Anhui Province, China. J. Clin. Microbiol. 43: 4301-4302 [Full Text]  
  • Baraniak, A., Fiett, J., Mrowka, A., Walory, J., Hryniewicz, W., Gniadkowski, M. (2005). Evolution of TEM-Type Extended-Spectrum {beta}-Lactamases in Clinical Enterobacteriaceae Strains in Poland. Antimicrob. Agents Chemother. 49: 1872-1880 [Abstract] [Full Text]  
  • Galan, J.-C., Morosini, M.-I., Baquero, M.-R., Reig, M., Baquero, F. (2003). Haemophilus influenzae blaROB-1 Mutations in Hypermutagenic {Delta}ampC Escherichia coli Conferring Resistance to Cefotaxime and {beta}-Lactamase Inhibitors and Increased Susceptibility to Cefaclor. Antimicrob. Agents Chemother. 47: 2551-2557 [Abstract] [Full Text]  
  • Shimamura, T., Ibuka, A., Fushinobu, S., Wakagi, T., Ishiguro, M., Ishii, Y., Matsuzawa, H. (2002). Acyl-intermediate Structures of the Extended-spectrum Class A beta -Lactamase, Toho-1, in Complex with Cefotaxime, Cephalothin, and Benzylpenicillin. J. Biol. Chem. 277: 46601-46608 [Abstract] [Full Text]  
  • Morosini, M. I., Ayala, J. A., Baquero, F., Martínez, J. L., Blázquez, J. (2000). Biological Cost of AmpC Production for Salmonella enterica Serotype Typhimurium. Antimicrob. Agents Chemother. 44: 3137-3143 [Abstract] [Full Text]  
  • Blazquez, J., Morosini, M.-I., Negri, M.-C., Baquero, F. (2000). Selection of Naturally Occurring Extended-Spectrum TEM beta -Lactamase Variants by Fluctuating beta -Lactam Pressure. Antimicrob. Agents Chemother. 44: 2182-2184 [Abstract] [Full Text]  
  • Poirel, L., Le Thomas, I., Naas, T., Karim, A., Nordmann, P. (2000). Biochemical Sequence Analyses of GES-1, a Novel Class A Extended-Spectrum beta -Lactamase, and the Class 1 Integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44: 622-632 [Abstract] [Full Text]